Physcion

Physcion

SCHEMBL486155

COc1cc(O)c2c(c1)C(=O)c1cc(C)cc(O)c1C2=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 5/20 1.00
ALDH1A1 P00352 4/20 1.00
MAPT P10636 3/20 1.00
ALOX15 P16050 2/20 1.00
KDM4E B2RXH2 2/20 1.00
GLA P06280 1/20 1.00
HPGD P15428 1/20 1.00
CYP3A4 P08684 3/20 0.70
AKR1B1 P15121 3/20 0.70
PIM1 P11309 2/20 0.70
MEN1 O00255 2/20 0.70
TSHR P16473 2/20 0.70
MAPK1 P28482 2/20 0.70
KMT2A Q03164 2/20 0.70
TDP1 Q9NUW8 2/20 0.70
CYP1A2 P05177 2/20 0.70
EPHX2 P34913 2/20 0.70
NPC1 O15118 1/20 0.70
PTP4A3 O75365 1/20 0.70
GMNN O75496 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Physcion SCHEMBL30425832 1.00 ELANE (1.00) ELANEALDH1A1MAPTALOX15KDM4E
Physcion SCHEMBL29404320 1.00 ELANE (1.00) ELANEALDH1A1MAPTALOX15KDM4E
SCHEMBL30140513 0.95 ELANE (0.90) ELANEALDH1A1MAPTALOX15KDM4E
SCHEMBL16226000 0.95 ELANE (0.90) ELANEALDH1A1MAPTALOX15KDM4E
SCHEMBL16226983 0.91 ELANE (0.83) ELANEALDH1A1MAPTALOX15KDM4E
SCHEMBL16226368 0.91 ELANE (0.83) ELANEALDH1A1MAPTALOX15KDM4E
SCHEMBL16227337 0.91 ELANE (0.83) ELANEALDH1A1MAPTALOX15KDM4E
Physcion SCHEMBL16226896 0.90 ELANE (0.82) ELANEALDH1A1MAPTALOX15KDM4E
Physcion SCHEMBL5015452 0.90 ELANE (0.81) ELANEALDH1A1MAPTALOX15KDM4E
Physcion SCHEMBL16932391 0.89 ELANE (0.79) ELANEALDH1A1MAPTALOX15KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4693 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122031441-A Application of physcion in preparation of medicine for treating fungal keratitis 青岛大学附属医院 2026-05-15 CN claimed
EP-4728059-A1 PROCESS TO PRODUCE ANTHRAQUINONE PIGMENTS AND DYES Teknologian Tutkimuskeskus VTT OY (FI) 2026-04-22 EP claimed
US-20260068884-A1 COMPOSITION USED FOR KILLING FUNGI AND METHOD FOR APPLYING COMPOSITION JIANGSU FLAG CHEMICAL INDUSTRY CO., LTD. (CN) 2026-03-12 US claimed
US-20260034158-A1 METHODS OF TREATING CANCER OF THE CENTRAL NERVOUS SYSTEM COMPRISING 5-ETHYNYL-2'-DEOXYURIDINE UNIV NORTH CAROLINA CHAPEL HILL (US) 2026-02-05 US claimed
US-20250360073-A1 SOLUBILIZING PIGMENTS EXTRACTED FROM FUNGI FOR APPLICATIONS SUCH AS COSMETIC PRODUCTS ADLER JESSE (US) 2025-11-27 US claimed
US-20250241869-A1 COMPOSITIONS AND METHODS COMPRISING DEOXY-PENTITOLS THE CHARLOTTE MECKLENBURG HOSPITAL AUTHORITY D/B/A ATRIUM HEALTH (US) 2025-07-31 US claimed
EP-4581931-A1 COMPOSITION USED FOR KILLING FUNGI AND METHOD FOR APPLYING COMPOSITION Jiangsu Flag Chemical Industry Co., Ltd. (CN) 2025-07-09 EP claimed
CN-120161158-A Method for measuring content of 12 components in supernatant tablet by high performance liquid chromatography 亳州市食品药品检验中心(亳州市药品和医疗器械不良反应(事件)监测中心) 2025-06-17 CN claimed
CN-120131704-A Hydrogel for promoting collagen production 江西科技师范大学 2025-06-13 CN claimed
EP-4561704-A2 USE OF GLYCOGEN METABOLISM INHIBITORS FOR THE TREATMENT OF CANCER The University Of Vermont (US) 2025-06-04 EP claimed
US-20030082101-A1 Accelerators for increasing the rate of formation of free radicals and reactive oxygen species CAVALIER DISCOVERY 2003-05-01 US claimed
WO-2002100478-A9 ACCELERATORS FOR INCREASING THE RATE OF FORMATION OF FREE RADICALS AND REACTIVE OXYGEN SPECIES CAVALIER DISCOVERY (US) 2003-03-27 WO claimed
WO-2002100478-A2 ACCELERATORS FOR INCREASING THE RATE OF FORMATION OF FREE RADICALS AND REACTIVE OXYGEN SPECIES CAVALIER DISCOVERY (US) 2002-12-19 WO claimed
CN-1310164-A Ararobinol and chrysophanol separating method CHEN GUANGYAO (CN) 2001-08-29 CN claimed
EP-0877608-A1 SENSITIZATION OF HER2/neu OVER-EXPRESSING CANCER CELLS TO CHEMOTHERAPEUTIC DRUGS THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1998-11-18 EP claimed
WO-1997027848-A9 SENSITIZATION OF HER2/neu OVER-EXPRESSING CANCER CELLS TO CHEMOTHERAPEUTIC DRUGS 1997-10-16 WO claimed
WO-1997027848-A1 SENSITIZATION OF HER2/neu OVER-EXPRESSING CANCER CELLS TO CHEMOTHERAPEUTIC DRUGS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1997-08-07 WO claimed
EP-0525073-B1 ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA DU PONT (US) 1994-05-25 EP claimed
EP-0525073-A1 ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA. DU PONT (US) 1993-02-03 EP claimed
WO-1991015954-A1 ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA E.I. DU PONT DE NEMOURS AND COMPANY (US) 1991-10-31 WO claimed